Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-DCs with Td Vaccine in Pediatric and Young Adult Brain Tumors
NCT03615404Phase 1Completed
- Sponsor
- Gary Archer (Duke University)
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, mRNA Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of dendritic cells pulsed with cytomegalovirus pp65 RNA in glioblastoma multiforme (GBM), malignant glioma and medulloblastoma, sponsored by Gary Archer (Duke University). Started Oct 2018; status: completed.
02
Drugs
dendritic cells pulsed with cytomegalovirus pp65 RNA
03
Conditions
glioblastoma multiforme (GBM)malignant gliomamedulloblastoma
Beyond the preview
Go deeper on NCT03615404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03615404.